Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Sarcoma 17Rhabdomyosarcoma 14Wilms Tumor 9Malignant mesenchymal tumor 7Gestational Trophoblastic Disease 6Kidney Neoplasms 5Neuroectodermal Tumors, Primitive, Peripheral 4Rhabdomyosarcoma, Embryonal 3Melanoma 3Fibrosarcoma 3Sarcoma, Ewing 2Rhabdomyosarcoma, Alveolar 2Ovarian Neoplasms 2Liposarcoma 2Hydatidiform Mole 2Hemangiosarcoma 2Hemangiopericytoma, Malignant 2Desmoplastic Small Round Cell Tumor 2Choriocarcinoma 2Testicular Neoplasms 1Teratoma, Ovarian 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Sarcoma, Alveolar Soft Part 1Rhabdoid Tumor 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pleuropulmonary blastoma 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Lymphoma 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1

Interventions

Nivolumab 143pembrolizumab 129Sunitinib 127Bevacizumab 71Everolimus 70Sorafenib 68cabozantinib 64Ipilimumab 61pazopanib 58Axitinib 57aldesleukin 51Magnetic Resonance Spectroscopy 43Cyclophosphamide 40Interleukin-2 38lenvatinib 36Radiosurgery 36Specimen Handling 33Interferon-alpha 32atezolizumab 29belzutifan 24temsirolimus 23Gemcitabine 23fludarabine phosphate 22Radiotherapy 18Interferon alpha-2 18Biopsy 18fludarabine 17durvalumab 17avelumab 17Paclitaxel 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Renal Cell × Dactinomycin × Clear all
NCT00335556 2017-07-21

Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors

Children's Oncology Group

Phase 2 Completed
291 enrolled 18 charts
Genitourinary

Carcinoma, Renal Cell, Wilms Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡